Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,902 | 91,648 | 137,408 | 33,347 | 41,002 |
| Marketable Securities | 46,618 | 27,070 | N/A | N/A | N/A |
| Receivables | 14,773 | 17,335 | 10,612 | N/A | N/A |
| TOTAL | $123,437 | $138,200 | $148,972 | $34,117 | $41,828 |
| Non-Current Assets | |||||
| PPE Net | 1,648 | 1,572 | 1,479 | 1,169 | 1,228 |
| Other Non-Current Assets | 2,899 | 1,249 | 1,248 | 1,212 | 1,381 |
| TOTAL | $4,547 | $2,821 | $2,727 | $2,381 | $2,609 |
| Total Assets | $127,984 | $141,021 | $151,699 | $36,497 | $44,436 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,624 | 6,887 | 482 | 1,018 | 2,410 |
| Accrued Expenses | 12,199 | 14,742 | 21,219 | 25,642 | 13,132 |
| TOTAL | $19,823 | $21,629 | $21,701 | $26,660 | $15,542 |
| Non-Current Liabilities | |||||
| TOTAL | $1,136 | $1,113 | $1,089 | $835 | $856 |
| Total Liabilities | $20,959 | $22,742 | $22,790 | $27,495 | $16,398 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,678 | 28,677 | 28,677 | 28,665 | 20,040 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -109,022 | -96,372 | -84,592 | -62,680 | -36,821 |
| Other shareholders' equity | -74 | -25 | 0 | 0 | 0 |
| TOTAL | $107,025 | $118,279 | $128,909 | $9,003 | $28,039 |
| Total Liabilities And Equity | $127,984 | $141,021 | $151,699 | $36,497 | $44,436 |